Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  73,126 results for ""Graft vs Host Disease""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.

  • Authors : Youngster I; Shamir Medical Center, Beer Yaacov, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology; Humans

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 Mar; Vol. 59 (3), pp. 409-416. Date of Electronic Publication: 2024 Jan 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Adolescent and Young Adult Patients with Vaginal Graft-vs-Host Disease and Hematocolpos Managed with Vaginal Stents: A Case Series.

Subjects: Hematocolpos*/Hematocolpos*/Hematocolpos*/complications ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/complications

  • Source: Journal of pediatric and adolescent gynecology [J Pediatr Adolesc Gynecol] 2024 Feb; Vol. 37 (1), pp. 78-86. Date of Electronic Publication: 2023 Oct 04.Publisher: Elsevier Science Country of Publication: United States NLM ID: 9610774 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Navigating the Complexity of Chronic Graft-vs-Host Disease: Canadian Insights into Real-World Treatment Sequencing.

  • Authors : Kim D; Princess Margaret Cancer Center, Toronto, Ontario, Canada.; Taparia M

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/diagnosis ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/drug therapy

  • Source: Transplantation proceedings [Transplant Proc] 2024 Mar; Vol. 56 (2), pp. 409-415. Date of Electronic Publication: 2024 Feb 10.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.

  • Authors : Bang CH; Department of Dermatology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Park HE

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Vitiligo*/Vitiligo*/Vitiligo*/epidemiology ; Vitiligo*/Vitiligo*/Vitiligo*/etiology

  • Source: JAMA dermatology [JAMA Dermatol] 2024 Feb 01; Vol. 160 (2), pp. 194-198.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.

  • Authors : Huang R; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing, China.; Chen T

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 220-226.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Ruxolitinib add-on therapy in steroid-refractory graft-vs-host disease following hematopoietic cell transplantation: A single institutional experience.

  • Authors : Wang YL; Division of Hematology/Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.; Chang TY

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/drug therapy ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Hematopoietic Stem Cell Transplantation*

  • Source: Pediatrics and neonatology [Pediatr Neonatol] 2024 Jan; Vol. 65 (1), pp. 85-86. Date of Electronic Publication: 2023 Nov 07.Publisher: Elsevier Country of Publication: Singapore NLM ID: 101484755 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease.

  • Authors : Bailey C; Division of Immunotherapy, Institute of Human Virology, Department of Surgery and Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Wei Y

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control ; Leukemia*/Leukemia*/Leukemia*/genetics ; Leukemia*/Leukemia*/Leukemia*/therapy

  • Source: Cell reports. Medicine [Cell Rep Med] 2023 Nov 21; Vol. 4 (11), pp. 101236. Date of Electronic Publication: 2023 Oct 11.Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Oral Manifestations of Graft vs. Host Disease: A Comprehensive Review for Best Practice in Dentistry.

  • Authors : Miranda M; Department of Clinical Sciences and Translational Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy.; Gianfreda F

Subjects: Dentists* ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology; Animals

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Nov 01; Vol. 59 (11). Date of Electronic Publication: 2023 Nov 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144

Record details

Read More Add to Saved list
×
Editorial & Opinion

The complex web of FasL: cell type-specific roles in affecting and controlling acute graft-vs-host disease.

  • Authors : Choy JC; Department of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada.

Subjects: Graft vs Host Disease*; Humans ; Fas Ligand Protein/Fas Ligand Protein/Fas Ligand Protein/metabolism

  • Source: Journal of leukocyte biology [J Leukoc Biol] 2023 Sep 01; Vol. 114 (3), pp. 202-204.Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease.

  • Authors : Wang B; Department of Hematology, Peking University First Hospital, Beijing, China.; Yin Y

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/diagnosis ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

  • Source: Transplantation proceedings [Transplant Proc] 2023 Sep; Vol. 55 (7), pp. 1706-1714. Date of Electronic Publication: 2023 Jun 27.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  73,126 results for ""Graft vs Host Disease""